ArticleScience advances2025

Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer.

Fu Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.